Zelrix Sumatriptan Patch & FDA Approval Process | Migraine.com
Links shared publicly online about this topic.
- 665total visits
Zelrix Sumatriptan Patch & FDA Approval Process | Migraine.com
View full resource at migraine.com
Tags: Migraine, Migraine Medication, Triptans, Headache, Vascular Headache, FDA, Imigran, Imitrex
Most Recently Shared on December 10, 2010 at 8:18 pm By:
Zelrix Sumatriptan Patch & FDA Approval Process | Migraine.com: http://bit.ly/hVDoTc via @migrainedotcom #migraine #fda
ingentaconnect The majority (7178%) of physicians would prescribe Zelrix [sumatr...
ingentaconnect.com — “ingentaconnect The majority (7178%) of physicians would prescribe Zelrix [sumatr...” View full resource at ingentaconnect.com
Most Recently Shared on October 10, 2011 at 8:41 pm By:
The majority (7178%) of physicians would prescribe Zelrix [sumatriptan patch] for acute migraine if it was price... http://t.co/4moKpfPs
Zelrix Migraine Patch - FDA Approval Delayed | Migraine.com
migraine.com — “The FDA issued a Complete Response Letter regarding the Migraine sumatriptan patch Zelrix, delaying FDA approval of this new medication.” View full resource at migraine.com
Most Recently Shared on September 6, 2011 at 3:11 pm By:
Zelrix #Migraine Patch - FDA Approval Delayed | Migraine.com http://t.co/vrblu5H via @MigraineDotCom @NupatheInc
Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today
medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.” View full resource at medpagetoday.com
Most Recently Shared on September 1, 2011 at 9:18 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: Sumatripan Patch Fails to Win FDA Nod - http://t.co/NONb90z from @medpagetoday #health #medicine
Migraine Patch Rejected by FDA | ThirdAge
thirdage.com — “NuPathe Inc's new migraine patch Zelrix has been rejected by the FDA, causing the likely release date to be pushed back six months.” View full resource at thirdage.com
Most Recently Shared on August 31, 2011 at 8:15 pm By:
Migraine Patch Rejected by FDA http://t.co/IB31njG
Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today
medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 1:44 pm By:
Sumatripan Patch Fails to Win FDA Nod http://t.co/lQOPPdq
Medical News: Sumatripan Patch Fails to Win FDA Nod - in Neurology, Migraines from MedPage Today
medpagetoday.com — “The FDA has turned down a transdermal patch formulation of the migraine drug sumatriptan, citing safety, chemistry, and manufacturing issues, its developer said.” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 1:41 pm By:
FDA turns down sumatriptan patch Zelrix for migraine: http://t.co/Y0w1dUb
NuPathe says FDA did not approve migraine patch - Yahoo! News
news.yahoo.com — “Read 'NuPathe says FDA did not approve migraine patch' on Yahoo! News. NuPathe Inc. said Tuesday that regulators did not approve its Zelrix migraine patch, and the company's shares lost almost half their value.” View full resource at news.yahoo.com
Most Recently Shared on August 30, 2011 at 6:51 pm By:
NuPathe says FDA did not approve migraine patch: NuPathe Inc. said Tuesday that regulators did not approve its ... http://t.co/MFsotoL
Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results - Yahoo! News
news.yahoo.com — “Read 'Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results' on Yahoo! News. Shares of NuPathe (PATH) are plunging today after the pharma company said the U.S. Food and Drug Administration declined to approve its Zelrix migraine patch.The FDA issued a complete response letter to the company, in which it acknowledge the established efficacy of the treatment, but raised questions regarding the chemistry, manufacturing and safety of the patch.NuPathe said it believe that it ” View full resource at news.yahoo.com
Most Recently Shared on August 30, 2011 at 6:51 pm By:
Pharma: NuPathe Migraine Patch Rejected; Another Blood Thinner Misses Results: Shares of NuPathe (PATH) are plu... http://t.co/S7lO7Gg
Migraine Patch Rejected by FDA | ThirdAge
thirdage.com — “NuPathe Inc's new migraine patch Zelrix has been rejected by the FDA, causing the likely release date to be pushed back six months.” View full resource at thirdage.com
Most Recently Shared on August 30, 2011 at 3:59 pm By:
Migraine Patch Rejected by FDA http://t.co/ncrLZyz
NuPathe: FDA wants more data on migraine patch - MarketWatch
marketwatch.com — “TEL AVIV (MarketWatch) -- NuPathe Inc., the Conshohocken, Pa., specialist in therapeutics for diseases of the central nervous system, said the U.S. Food and Drug Administration declined to approve its proposed migraine patch and wants more information on the drug, called Zelrix. NuPathe said it won't meet its target of launching the patch in first-half 2012. In a Complete Response Letter, NuPathe said in a Tuesday statement, the FDA "acknowledged that NuPathe established the efficacy of” View full resource at marketwatch.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
NuPathe: FDA wants more data on migraine patch: TEL AVIV (MarketWatch) -- NuPathe Inc., the Conshohocken, Pa., s... http://t.co/8GP0Ewj
FDA Rejects NuPathe Migraine Patch - TheStreet
thestreet.com — “NuPathe may need to conduct additional studies before resubmitting Zelrix for approval again.” View full resource at thestreet.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
FDA Rejects NuPathe Migraine Patch: CONSHOHOCKEN, Pa. (TheStreet) -- U.S. regulators rejected NuPathe's migraine... http://t.co/CjQasgc
FDA Requests Additional Information Regarding NuPathe's Migraine Patch in Complete Response Letter
marketwire.com — “CONSHOHOCKEN, PA--(Marketwire - Aug 30, 2011) - NuPathe Inc. (NASDAQ: PATH) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food @ Drug Administration (FDA) regarding the New Drug Application (NDA) for its migraine patch (NP101 or Zelrix). A CRL is issued by the FDA's...” View full resource at marketwire.com
Most Recently Shared on August 30, 2011 at 12:43 pm By:
FDA Requests Additional Information Regarding NuPathe's Migraine Patch in Complete Response Letter: CONSHOHOCKE... http://t.co/rhjDXXz
NuPathe shares in meltdown after FDA rejects migraine patch app - FierceBiotech
fiercebiotech.com — “The FDA has handed NuPathe a complete response letter detailing demands for new information on its experimental migraine patch, Zelrix (NP101). But even after scrambling to try and reassure investors Read more...” View full resource at fiercebiotech.com
Most Recently Shared on August 30, 2011 at 12:34 pm By:
NuPathe shares in meltdown after FDA rejects migraine patch app. http://t.co/JAMKwAX
Migraine-Treating Bandages - The Zelrix Migraine Patch Fights Migraines With Electric Medication
trendhunter.com — “Zelrix Migraine Patch - Migraine sufferers are about to get one more treatment option in the form of the new Zelrix Migraine Patch. The Zelrix Migraine Patch has recently ...” View full resource at trendhunter.com
Most Recently Shared on January 26, 2011 at 9:29 pm By:
Trend Hunter Health Health Magazine
Migraine-Treating Bandages - The Zelrix Migraine Patch Fights Migraines With Electric Medication #Health: http://bit.ly/fkkRSU
Zelrix electronic anti-migraine patch heads to the FDA for review -- Engadget
engadget.com — “Zelrix electronic anti-migraine patch heads to the FDA for review -- Engadget” View full resource at engadget.com
Most Recently Shared on January 24, 2011 at 5:59 am By:
Zelrix electronic anti-migraine patch heads to the FDA for review: We've seen some electronic devices that prom... http://engt.co/f4lztK
Advertisement
